Showing results (521-530 of 744) with videos related to

Sort By:
Pageof 75
European Urology|October 25, 2012
Contemporary grading for prostate cancer: implications for patient careFadi Brimo, Rodolfo Montironi, Lars Egevad, et al.
Human Pathology|October 20, 2004
Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinomaNathalie Rioux-Leclercq, Jean-Guy Delcros, Jean-Yves Bansard, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
The American Journal of Surgical Pathology|January 5, 2021
Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 CasesPedram Argani, Derrick W Q Lian, Abbas Agaimy, et al.
World Journal of Urology|February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year resultsNeal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 20, 2009
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomasTamara L Lotan, Antoun Toubaji, Roula Albadine, et al.
European Urology|March 17, 2012
A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimensSamson W Fine, Mahul B Amin, Daniel M Berney, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2009
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinomaRoula Albadine, Mathieu Latour, Antoun Toubaji, et al.
Pageof 75